LIAISON XL MUREX Control Anti-HBe

GUDID 28056771103439

DIASORIN SPA

Hepatitis B virus e-antigen total antibody IVD, control

• Primary Device ID: 28056771103439
• NIH Device Record Key: fdd8a1da-e654-4456-a822-519e162a2c11
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: LIAISON XL MUREX Control Anti-HBe
• Version Model Number: 318161
• Company DUNS: 630822989
• Company Name: DIASORIN SPA
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: true
• Device Combination Product: false
• Single Use: false
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Device Identifiers

Device Issuing Agency	Device ID
GS1	08056771103435 [Primary]
GS1	28056771103439 [Package]; Contains: 08056771103435; Package: [20 Units]; In Commercial Distribution

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2021-04-21
• Device Publish Date: 2021-04-13

Devices Manufactured by DIASORIN SPA

• 08056771100199 - LIAISON® anti-HAV: 2026-01-19
• 08056771100205 - LIAISON® Control anti-HAV: 2026-01-19
• 08056771100571 - LIAISON® Rubella IgG: 2026-01-19
• 08056771100588 - LIAISON® Rubella IgG TRI-Controls: 2026-01-19
• 08056771100618 - LIAISON® Treponema Assay: 2026-01-19
• 08056771101943 - LIAISON® CMV IgM: 2026-01-15
• 08056771104029 - LIAISON® Biotrin Parvovirus B19 IgG Plus: 2024-04-16 Italy manufactured kit.
• 08056771104036 - LIAISON® Biotrin Control Parvovirus B19 IgG Plus: 2024-04-16 Italy manufactured kit.